Addex Therapeutics Stock Price on December 31, 2022

ADXN Stock  USD 10.78  0.23  2.18%   
Below is the normalized historical share price chart for Addex Therapeutics extending back to January 29, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Addex Therapeutics stands at 10.78, as last reported on the 11th of November 2024, with the highest price reaching 11.68 and the lowest price hitting 10.45 during the day.
IPO Date
29th of January 2020
200 Day MA
10.5832
50 Day MA
10.3475
Beta
1.874
 
Covid
If you're considering investing in Addex Stock, it is important to understand the factors that can impact its price. Addex Therapeutics appears to be slightly risky, given 3 months investment horizon. Addex Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0976, which signifies that the company had a 0.0976% return per unit of standard deviation over the last 3 months. By analyzing Addex Therapeutics' technical indicators, you can evaluate if the expected return of 0.74% is justified by implied risk. Please makes use of Addex Therapeutics' risk adjusted performance of 0.0805, and Mean Deviation of 3.94 to double-check if our risk estimates are consistent with your expectations.
  
At this time, Addex Therapeutics' Common Stock Total Equity is very stable compared to the past year. As of the 11th of November 2024, Common Stock Shares Outstanding is likely to grow to about 78 M, while Total Stockholder Equity is likely to drop about 1.1 M. . At this time, Addex Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 11th of November 2024, Price To Book Ratio is likely to grow to 346.47, while Price To Sales Ratio is likely to drop 222.62. Addex Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0976

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsADXN
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 7.54
  actual daily
67
67% of assets are less volatile

Expected Return

 0.74
  actual daily
14
86% of assets have higher returns

Risk-Adjusted Return

 0.1
  actual daily
7
93% of assets perform better
Based on monthly moving average Addex Therapeutics is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Addex Therapeutics by adding it to a well-diversified portfolio.
Price Book
0.7805
Enterprise Value Ebitda
(0.76)
Price Sales
14.4673
Shares Float
34.2 M
Wall Street Target Price
30.04

Addex Therapeutics Valuation on December 31, 2022

It is possible to determine the worth of Addex Therapeutics on a given historical date. On December 31, 2022 Addex was worth 12.6 at the beginning of the trading date compared to the closed value of 12.6. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Addex Therapeutics stock. Still, in general, we apply an absolute valuation method to find Addex Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Addex Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Addex Therapeutics' related companies.
 Open High Low Close Volume
  12.20    12.60    12.01    12.60    6,086  
12/30/2022
  12.60    13.09    11.90    12.60    6,223  
  13.09    15.00    13.00    13.60    4,332  
Backtest Addex Therapeutics  |  Addex Therapeutics History  |  Addex Therapeutics Valuation   PreviousNext  
Open Value
12.6
12.6
Closing Value
35.23
Upside

Addex Therapeutics Trading Date Momentum on December 31, 2022

On January 03 2023 Addex Therapeutics was traded for  13.60  at the closing time. The top price for the day was 15.00  and the lowest listed price was  13.00 . The trading volume for the day was 4.3 K. The trading history from January 3, 2023 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 7.94% . The overall trading delta against the current closing price is 22.38% .

Addex Therapeutics Fundamentals Correlations and Trends

By evaluating Addex Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Addex Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Addex financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Addex Therapeutics Stock history

Addex Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Addex is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Addex Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Addex Therapeutics stock prices may prove useful in developing a viable investing in Addex Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding74.3 M78 M
Net Loss-18.7 M-17.8 M

Addex Therapeutics Stock Technical Analysis

Addex Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Addex Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Addex Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Addex Therapeutics Period Price Range

Low
November 11, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Addex Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Addex Therapeutics November 11, 2024 Market Strength

Market strength indicators help investors to evaluate how Addex Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Addex Therapeutics shares will generate the highest return on investment. By undertsting and applying Addex Therapeutics stock market strength indicators, traders can identify Addex Therapeutics entry and exit signals to maximize returns

Addex Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Addex Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Addex Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Addex to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Addex Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Addex Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Addex Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Addex Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Addex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(19.18)
Revenue Per Share
1.2
Quarterly Revenue Growth
(0.82)
Return On Assets
(0.62)
Return On Equity
(1.26)
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.